兴华创新医疗6个月持有混合发起A(013920)财务指标
| |
2024-06-30 |
2023-12-31 |
2023-06-30 |
2022-12-31 |
| 本期已实现收益 |
-2,312,752.77 |
-7,470,056.79 |
-3,477,035.99 |
-2,031,398.47 |
| 本期利润 |
-3,373,262.86 |
-4,685,809.30 |
-2,478,220.86 |
-5,063,746.40 |
| 加权平均基金份额本期利润 |
-0.16 |
-0.20 |
-0.10 |
-0.17 |
| 本期加权平均净值利润率(%) |
-28.22 |
-25.13 |
-11.81 |
-20.62 |
| 本期基金份额净值增长率(%) |
-24.29 |
-23.21 |
-12.45 |
-14.17 |
| 期末可供分配利润 |
-8,832,322.37 |
-9,046,467.95 |
-5,878,094.48 |
-3,635,612.69 |
| 期末可供分配基金份额利润 |
-0.50 |
-0.39 |
-0.25 |
-0.14 |
| 期末基金资产净值 |
8,754,926.84 |
15,349,159.74 |
17,599,350.34 |
21,652,595.72 |
| 期末基金份额净值 |
0.50 |
0.66 |
0.75 |
0.86 |
| 基金份额累计净值增长率(%) |
-50.22 |
-34.25 |
-25.04 |
-14.38 |
微信公众号
证券之星APP
基本资料
